Aram A Musaelyan

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 20, 2026
Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia.

|Oct 28, 2024
Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer.

Aram A Musaelyan, Svetlana V Odintsova, Karina A Musaelyan

|Jul 05, 2024
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report.

Aram A Musaelyan, Ekaterina M Anokhina, Alina I Turdubaeva

Pageof 1

Frequent Collaborators

2 joint publications

Evgeny N Imyanitov

2 joint publications

Svetlana V Odintsova

2 joint publications

Sergey V Orlov

1 joint publications

Ekaterina M Anokhina